H2S-Releasing JAK1-Targeting Molecular Hybrids as a Multifunctional Strategy for Cutaneous Wound Repair
Year: 2026
Type: article
Abstract: To integrate complementary pharmacological properties relevant to cutaneous wound repair, we designed and synthesized six novel molecular hybrids combining a JAK1-targeting 7H-pyrrolo[2,3-d]pyrimidine scaffold with selected hydrogen sulfide (H2S)-releasing moieties. The compounds were characterized for their H2S-releasing properties and evaluated in human HaCaT keratinocytes, using abrocitinib, a selective JAK1 inhibitor, as a reference compound. Compounds II, III, and V emerged as the most promising derivatives, displaying marked pro-migratory activity in both scratch wound and Transwell assays, with effects exceeding those of the corresponding H2S donors and abrocitinib under the tested conditions. Notably, compounds II, III, and V exhibited distinct cysteine-dependent H2S-release profiles, characterized by a progressive increase followed by a relatively stable plateau during the 30-min amperometric assay performed at 100 µM. Molecular docking studies supported the ability of the selected hybrids to retain key interactions within the JAK1 binding pocket, while highlighting linker-dependent differences in ligand orientation. Further biological characterization showed that compounds II and V modulated the expression of the extracellular matrix-related genes COL1A1, MMP2, and MMP9, whereas compounds II, III, and V attenuated IFN-γ/TNF-α-induced STAT1 phosphorylation with effects comparable to abrocitinib. Under inflammatory conditions, compounds II and V also counteracted the cytokine-induced reduction in COL1A1 expression. Overall, these findings identify compounds II, III, and V as promising multifunctional H2S-releasing molecular hybrids and support the development of H2S-based hybrid pharmacological strategies combining H2S-releasing properties with enhanced keratinocyte migration, modulation of extracellular matrix-related responses, and attenuation of cytokine-induced STAT1 activation.
Source: Antioxidants
Authors: Pierfrancesco Cinque(Investigation, Methodology, Writing – original draft), Fabio Somma(Formal analysis, Investigation, Methodology, Writing – original draft), Benedetta Romano(Formal analysis, Investigation, Methodology), Giuseppe Caliendo(Visualization, Writing – review & editing), Vincenzo Santagada(Writing – review & editing), Elisa Perissutti(Visualization, Writing – review & editing), Elisa Magli(Validation, Visualization), Stefania Vertuccio(Validation, Visualization), Giorgia Andreozzi(Validation, Visualization), Rosa Sparaco(Resources, Visualization), Beatrice Severino(Data curation, Methodology), Ferdinando Fiorino(Data curation, Investigation), Letizia Dani(Investigation, Methodology), Valentina Citi(Formal analysis, Methodology), Alma Martelli(Data curation, Methodology), Vincenzo Calderone(Data curation, Visualization, Writing – review & editing), Roberta Palladino(Conceptualization, Methodology), Eugenia Romano(Investigation, Visualization), Lidia Ciriaco(Investigation, Resources), Barbara Maglione(Investigation, Resources), Giuseppe Ercolano(Conceptualization, Project administration, Supervision, Writing – review & editing), Angela Ianaro(Supervision, Visualization, Writing – review & editing), Francesco Frecentese(Conceptualization, Funding acquisition, Project administration, Writing – review & editing)
Language: English
Topic: Wound Healing and Treatments
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236630142
